Showing results (71-80 of 205) with videos related to

Sort By:
Pageof 21
Eye (London, England)|November 26, 2020
Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidenceKelvin Yi Chong Teo, Vuong Nguyen, Daniel Barthelmes, et al.
Progress in Retinal and Eye Research|January 7, 2018
Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitorsHemal Mehta, Adnan Tufail, Vincent Daien, et al.
Retina (Philadelphia, Pa.)|February 20, 2020
PREVALENCE AND RISK FACTORS FOR THE DEVELOPMENT OF PHYSICIAN-GRADED SUBRETINAL FIBROSIS IN EYES TREATED FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONKelvin Yi Chong Teo, Aaron W Joe, Vuong Nguyen, et al.
Progress in Retinal and Eye Research|October 28, 2023
From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedemaPierre-Henry Gabrielle, Hemal Mehta, Daniel Barthelmes, et al.
Clinical & Experimental Ophthalmology|February 8, 2026
Twelve-Month Real-World Outcomes of Faricimab for Treatment-Naive Neovascular AMD in AustraliaMark Gillies, Yohei Hashimoto, Rahman Nazari, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 23, 2024
A Novel Technique of Aseptic Manufacture of Autologous Serum Eye Drops (ASEDs) and Sterility Analysis of the Bottled OphtiolesFrank Blaser, Isabelle Meneau, Daniela Mihic-Probst, et al.
Clinical & Experimental Ophthalmology|July 23, 2022
One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusionNancy Wang, Adrian Hunt, Vuong Nguyen, et al.
Ophthalmology. Retina|May 19, 2022
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! RegistryPierre-Henry Gabrielle, Vuong Nguyen, Louis Arnould, et al.
Investigative Ophthalmology & Visual Science|March 1, 2006
Quantitative analysis of OCT characteristics in patients with achromatopsia and blue-cone monochromatismDaniel Barthelmes, Florian K Sutter, Malaika M Kurz-Levin, et al.
Clinical & Experimental Ophthalmology|June 15, 2021
Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greaterElisa E Cornish, Vuong Nguyen, Stephanie Young, et al.
Pageof 21